Association of Adverse Events Following Immunisation with COVID-19 Vaccine and Lifestyle of Individuals: A Cross-sectional Analytical Survey

Author:

Rao Poojita Santosh,Santosh Vasavi,Langade Deepak

Abstract

Introduction: The Coronavirus Disease-2019 (COVID-19) pandemic, being an emerging world health issue, has led to the swift development of vaccines. Various lifestyles, health conditions, and behaviours affect the body’s reaction to immunisation. Aim: To evaluate the association of Adverse Effects Following Immunisation (AEFI) with different lifestyles and health patterns. Materials and Methods: A cross-sectional online epidemiological analytical survey in study population across India was carried out in Mumbai, India, from 1st June 2021 to 21st June 2021, using Google form survey. It included a sample of 586 responders. A questionnaire consisting of 26 questions regarding lifestyle habits and AEFIs following COVID-19 vaccine administration was distributed. Questions about lifestyle were obtained using Simple Lifestyle Indicator Questionnaire (SLIQ) which includes questions regarding diet, activity/exercise, alcohol consumption, smoking, and stress. Association between the SLIQ score and number and duration of AEFI was determined. Measurement data was presented as means with standard deviation. The SLIQ scores and age were compared between the different groups (AEFI present/absent, no. of AEFI, duration of AEFI) using one-way analysis of variance (ANOVA). Results: The incidence of reported AEFI was n=577 (76.4%). The most frequently reported AEFI was redness, n=328 (74.38%) followed by pain, n=233 (52.83%), swelling n=233 (52.83%) and fever n=222 (50.34%). It was observed that those with a higher SLIQ score, had an increased number and duration of AEFI (p=0.001, ANOVA). With increase in age, number and duration of AEFI experienced decreased (p<0.0001, ANOVA). Conclusion: Balanced diet, mild to moderate exercise, abstinence from smoking and alcohol, reduced stress and younger age increase the number of AEFI, indicating a robust immune response.

Publisher

JCDR Research and Publications

Subject

Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3